LABRIDA - FOR EFFICIENT MAINTENANCE OF DENTAL IMPLANTS TO PREVENT PERI-IMPLANTITIS!

The Board

Tore Heldrup Rasmussen (MBA), Chairman of the board:

  • Rasmussen has held board and chairman positions at several public and stock listed companies, including Natural ASA (now Aker BioMarine ASA) and NSB (Norwegian railroads), as well as Sarsia Life Science Fund. He has industrial background from Orkla AS and P&G (Branded goods), partner at Implement Consulting Group, and now EVP commercial operations at Norwegian Property ASA. He has been instrumental in developing several early stage Life Science companies.

Anders Holmén (DDS), Board member:

  • Holmén has more than 25 years’ experience from the dental implant industry, in positions as clinical director and head of Product and therapy management in Astra Tech (now Dentsply, Inc.). He has also been assistant professor at Göteborg’s University and visiting professor at University of Connecticut.

Kathryn M. Baker (MBA), Board member:

  • Baker has six years experience from McKinsey & Co as well as 15 years at Private Equity (Reiten & co). She serves as board member of several listed companies, including AKASTOR (Aker Solutions ASA), Sevan Marine ASA and Agasti Holding. She is also at the board of directors at Bank of Norway.

Caspar Wohlfahrt (PhD, DDS, MSc, Specialist in Periodontology), Board member:

  • Wohlfahrt holds a part time position as Associate professor at University of Oslo, Institute of clinical dentistry, focusing his post-doctoral work on management of peri-implant disease (which is also core for his PhD thesis). Further, he maintains private practice activities as a periodontist, and is a widely used lecturer for dentists on dental implants. Previously, Wohlfahrt has worked as product specialist at Biora AB (now Straumann AG), and is a patent holder of the product TiBrush™, marketed by Straumann. Wohlfart is head of clinical development in LABRIDA AS.

Also supporting the company is co-founder Ståle Petter Lyngstadaas (PhD, DDS), Professor at Department for Biomaterials, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Norway. He has previously held the position as Research Director at BIORA, AB (NASDAQ, merged into Straumann AG), with responsibility for patents.